Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.
Read Full NewsFrom 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care evolved from near-certain death to precise, life-extending therapies.
Pegfilgrastim helps prevent myelosuppression in women undergoing chemotherapy for breast cancer but can also cause severe bone pain. A new study suggests a simple solution.
1.
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
2.
FDA Approves New Drug Combo for RR Multiple Myeloma
3.
November 2023, Medical Bulletin 04/.
4.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
5.
FDA approves Blenrep for relapsed or refractory multiple myeloma
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies
3.
The Unseen Danger of Anal Cancer: How to Protect Yourself
4.
Sorafenib: Understanding the science behind a powerful cancer drug
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge